Revenue: The sum of all revenue fields included for a company's operating activities.
Aquestive Therapeutics, Inc. (AQST) had Revenue of $8.72M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$8.72M |
$-22.93M |
|
$3.65M |
|
$5.07M |
|
$28.09M |
|
$-19.36M |
|
$-3.56M |
|
$-22.93M |
|
$-22.93M |
|
$-22.93M |
|
$-22.93M |
|
$-22.93M |
|
$-22.93M |
|
$-19.36M |
|
$-16.48M |
|
95.50M |
|
95.50M |
|
$-0.24 |
|
$-0.24 |
|
| Balance Sheet Financials | |
$89.17M |
|
$3.80M |
|
$13.06M |
|
$102.23M |
|
$18.30M |
|
$33.75M |
|
$144.87M |
|
$163.16M |
|
$-60.93M |
|
$-60.93M |
|
$-60.93M |
|
99.32M |
|
| Cash Flow Statement Financials | |
$-23.40M |
|
$-0.14M |
|
$20.65M |
|
$71.55M |
|
$68.66M |
|
$-2.89M |
|
$1.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.87 |
|
-- |
|
-- |
|
-1.24 |
|
-0.55 |
|
58.12% |
|
-222.08% |
|
-222.08% |
|
-- |
|
-262.96% |
|
-262.96% |
|
$-23.54M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.51 |
|
0.83 |
|
107.79 |
|
37.63% |
|
37.63% |
|
-22.43% |
|
84.35% |
|
$-0.61 |
|
$-0.25 |
|
$-0.24 |
|